{
    "code": "52028151",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52028151",
    "time": "2023-08-10 22:24:44",
    "許可證字號": "衛部藥輸字第028151號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/08\/30",
    "發證\/登錄日期": "110\/08\/30",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202815107",
    "中文品名": "侖昕妥注射液150毫克\/15毫升及稀釋液250毫升",
    "英文品名": "XENLETA (Lefamulin) Injection 150mg\/15mL, XENLETA Diluent 250 mL Solution",
    "適應症": "適用於治療由以下易感微生物所引起之成人社區型細菌性肺炎：肺炎鏈球菌(Streptococcus pneumoniae)、金黃色葡萄球菌(Staphylococcus aureus) (對methicillin敏感的分離株)、流感嗜血桿菌(Haemophilus influenzae)、嗜肺性退伍軍人桿菌(Legionella pneumophila)、肺炎黴漿菌(Mycoplasma pneumoniae)與肺炎披衣菌(Chlamydophila pneumoniae)」。",
    "劑型": "270注射劑",
    "包裝": "15毫升type I玻璃小瓶裝，6小瓶\/盒，搭配250毫升PP塑膠袋裝稀釋液，6袋\/盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "新成分",
    "監視期限": "115\/08\/30",
    "主成分略述": "lefamulin acetate",
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "台灣住友醫藥股份有限公司",
    "申請商地址": "臺北市大同區南京西路62號15樓之2及15樓之3",
    "主製造廠": [
        {
            "製造廠名稱": "PATHEON ITALIA S.P.A.",
            "製造廠廠址": "VIALE G.B. STUCCHI, 110-20900 MONZA (MB), ITALY",
            "製造廠公司地址": "",
            "製造廠國別": "ITALY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FRESENIUS KABI NORGE AS",
            "製造廠廠址": "SVINESUNDSVEIEN 80, HALDEN, NO-1788, NORWAY",
            "製造廠公司地址": "",
            "製造廠國別": "NORWAY",
            "製程": "稀釋液"
        },
        {
            "製造廠名稱": "SHARP CORPORATION",
            "製造廠廠址": "7451 KEEBLER WAY , ALLENTOWN , PENNSYLVANIA 18106 , USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "包裝"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812002900",
            "成分名稱": "lefamulin acetate",
            "含量描述": "(as free base)",
            "含量": "158.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "0 PI_ XENLETA IV_version 1-111-04-27.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52028151&Seq=001&Type=9"
        },
        {
            "title": "5. Label_diluent_Citrate Bag FRESENIUS-111-04-27.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52028151&Seq=005&Type=8"
        },
        {
            "title": "4. Xenleta Vial_Label-111-04-27.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52028151&Seq=004&Type=8"
        },
        {
            "title": "3. Diluent carton-111-04-27.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52028151&Seq=003&Type=8"
        },
        {
            "title": "2. Xenleta injection carton-111-04-27.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52028151&Seq=002&Type=8"
        },
        {
            "title": "1.XENLETA IV and diluent label_Chinese-111-04-27.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52028151&Seq=001&Type=8"
        }
    ]
}